TLR9 and neoplasm: Thirty-seven days after tumor challenge, all mice in the PBS group had died, whereas at 90 days post-tumor implantation, 20% of mice exhibited no tumors in the OCT4 + TLR9 group (P < 0.01) (Figure 3D).